| DOCK1 — Dedicator of cytokinesis protein 1 | |
|---|---|
| Symbol | DOCK1 |
| Full Name | Dedicator of cytokinesis protein 1 |
| Chromosome | 10q26.3 |
| NCBI Gene | 1791 |
| Ensembl | ENSG00000123146 |
| OMIM | 606003 |
| UniProt | Q8IU85 |
| Diseases | Parkinson's Disease, Cancer |
| Expression | Brain, Heart, Liver |
DOCK1 is a gene implicated in neurodegenerative diseases. This page provides comprehensive information about this gene, its functions, and its relevance to disease mechanisms.
DOCK1 is a guanine nucleotide exchange factor (GEF) for Rac GTPases. It plays critical roles in actin cytoskeleton reorganization, cell migration, and phagocytosis. In neurons, DOCK1 is involved in dendritic spine formation and synaptic plasticity.
The gene encodes a protein that plays important roles in normal neuronal function and survival. Understanding its normal function provides insight into how dysregulation contributes to neurodegenerative processes in diseases such as Alzheimer's disease, Parkinson's disease, and ALS.
DOCK1 encodes a protein involved in various cellular processes relevant to neuronal health. The protein localizes to specific cellular compartments and participates in signaling pathways that regulate:
DOCK1 is expressed in Brain, Heart, Liver. This expression pattern suggests roles in both central nervous system function and peripheral tissues. In the brain, expression is often enriched in specific neuronal populations.
Alterations in DOCK1 expression or function have been reported in Alzheimer's disease brain tissue. Changes may contribute to amyloid processing, tau pathology, synaptic dysfunction, or neuronal loss.
DOCK1 has been implicated in Parkinson's disease pathogenesis through roles in dopaminergic neuron survival, protein aggregation, or mitochondrial dysfunction.
Depending on its specific function, DOCK1 may also play roles in other neurodegenerative conditions including ALS, Huntington's disease, and frontotemporal dementia.
Understanding the role of DOCK1 in neurodegeneration may lead to therapeutic strategies targeting: